REPL
Replimune Group Inc
Halal Rating :
Last Price
$10.13
Last updated:
Market Cap
-
7D Change
-6.98%
1 Year Change
29.04%
Company Overview
Industries
Exchange
Next Earnings Date
Replimune Group Inc is a clinical-stage biotechnology company focused on developing oncolytic immunotherapies to treat cancer. The company's proprietary RPx platform is designed to generate potent new oncolytic immunotherapies that maximize the direct and indirect immune-mediated anti-tumor effects. They are developing novel therapies that are intended to treat a broad range of solid tumors.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Replimune Group Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.